Shot chasers: big pharma’s covid-19 boost

episode

The Intelligence from The Economist not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from The Intelligence from The Economist

Ire and ICE: the toll of America’s deportations 23 min · 03 Sep 2026

Right in front: AfD could win German state 23 min · 02 Sep 2026

After the flood: Nepal’s ongoing rescue 16 min · 01 Sep 2026

Stars in their AIs: tech is changing Hollywood 20 min · 31 Aug 2026

Bots on the ground: China leads humanoid race 24 min · 28 Aug 2026

Big shot: does a cancer vaccine work? 22 min · 27 Aug 2026

All episodes from The Intelligence from The Economist →

Report any issue

Source

Recorded26 May 2020

Publisheraccess.acast.com ↗

Handlerec:7761895

Show notes

The pandemic has caused a shift in how drug firms are viewed: their capacity for big-money innovation will give them immunity in the crisis. Widespread homeworking will have broad consequences, from commercial-property values to urban demographics. And a seemingly innocuous Hong Kong history exam is a window into the territory’s increasingly fraught politics. For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/radiooffer Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in